CDKN2A and astrocytoma (excluding glioblastoma): Importantly, the presence of CDKN2A HD (with pathologists’ p16 score of 1%) upgraded one IDH-mutant astrocytoma without microvascular proliferation or palisading necrosis to grade 4 (Additional file 1: Data 1).